## Critical Issues (must fix)
- [ ] **Section "The Compliance CI/CD Pipeline..."** contains an unverified claim: "This satisfies the EU AI Act's requirement for a continuous risk management system." The EU AI Act is not mentioned or supported by the provided research findings. This claim must be removed or replaced with a supported statement about continuous monitoring, which is discussed in the research's "Open Questions" section.
- [ ] **Missing SEO Structure Element:** The SEO strategy recommends an H2 section titled **"From Testing to Validation: Meeting FDA AI/ML Guidance."** This section is absent from the draft. The draft must be revised to include a dedicated section that explicitly bridges the technical evaluation process to the regulatory expectations outlined in the research (e.g., FDA's TPLC, validation requirements from 21 CFR Part 820, the paradigm of clinical trials like Baden et al., 2021). This is a core part of the article's promised synthesis.

## Suggestions (should fix)
- [ ] **Word Count & Depth:** The draft is approximately 1700 words, below the target range (1800-2200 per SEO; 2500-3500 per editorial guidelines). The new section on FDA guidance will add length. Furthermore, to meet the depth requirement, consider expanding on the "Core Challenge" or "Inevitable Limits" sections with more concrete examples of PII hallucination or infrastructure testing.
- [ ] **Clarity & Sentence Length:** Several sentences are long and complex. Actively break them down.
    *   Example (Introduction): "The alternative is to treat compliance not as a post-hoc checklist, but as an integrated, automated evaluation layer that fails your CI pipeline before bad code ships." → Consider: "The alternative is eval-driven compliance. Treat compliance as an integrated, automated evaluation layer. This layer fails your CI pipeline before non-compliant code ships."
- [ ] **Hedge Words:** Remove unnecessary qualifiers to strengthen tone.
    *   Example: "This is **likely** a hallucinated detail..." → "This is a hallucinated detail..."
    *   Example: "You **might** consider..." → "Consider..."

## Minor Notes (nice to have)
- [ ] **Active Voice:** Check for passive constructions and convert to active where it improves clarity and authority.
    *   Example: "A model can be evaluated..." → "You must evaluate a model..."
- [ ] **Code Comments:** The code examples are good. Ensure any inline comments are maximally clear for the target technical audience.

**DECISION: REVISE**

Please address the **Critical Issues** and consider the **Suggestions**. Return the revised draft for final approval. Focus the revision on integrating the FDA validation section and removing the unsupported EU AI Act reference, while using the opportunity to enhance depth and clarity.